相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer
Irene Casanova-Salas et al.
EUROPEAN UROLOGY (2021)
Perlecan/HSPG2: Signaling role of domain IV in chondrocyte clustering with implications for Schwartz-Jampel Syndrome
Jerahme R. Martinez et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop
Huiling Yang et al.
ANTI-CANCER DRUGS (2018)
Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells
Brian J. Grindel et al.
SCIENTIFIC REPORTS (2018)
Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome
Sungyong You et al.
CANCER RESEARCH (2016)
Single molecule force measurements of perlecan/HSPG2: A key component of the osteocyte pericellular matrix
Sithara S. Wijeratne et al.
MATRIX BIOLOGY (2016)
HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer
Sylvia Mahara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
Brian Grindel et al.
ONCOTARGET (2016)
Balancing spatially regulated β-actin translation and dynamin-mediated endocytosis is required to assemble functional epithelial monolayers
Lissette A. Cruz et al.
CYTOSKELETON (2015)
The Phyre2 web portal for protein modeling, prediction and analysis
Lawrence A. Kelley et al.
NATURE PROTOCOLS (2015)
RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization
Gina Chia-Yi Chu et al.
ENDOCRINE-RELATED CANCER (2014)
Transcriptional Activation by NFkB Increases Perlecan/HSPG2 Expression in the Desmoplastic Prostate Tumor Microenvironment
Curtis R. Warren et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior
B. J. Grindel et al.
MATRIX BIOLOGY (2014)
Border patrol: Insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders
Mary C. Farach-Carson et al.
MATRIX BIOLOGY (2014)
Neuropilins lock secreted semaphorins onto plexins in a ternary signaling complex
Bert J. C. Janssen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Structural basis of semaphorin-plexin signalling
Bert J. C. Janssen et al.
NATURE (2010)
Structural basis for semaphorin signalling through the plexin receptor
Terukazu Nogi et al.
NATURE (2010)
SitePredicting the cleavage of proteinase substrates
Jelle Verspurten et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Diverse Cell Signaling Events Modulated by Perlecan
John M. Whitelock et al.
BIOCHEMISTRY (2008)
A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation
Mary C. Farach-Carson et al.
MATRIX BIOLOGY (2008)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
Perlecan - a multifunctional extracellular proteoglycan scaffold
Mary C. Farach-Carson et al.
GLYCOBIOLOGY (2007)
Actin at cell-cell junctions is composed of two dynamic and functional populations
JK Zhang et al.
JOURNAL OF CELL SCIENCE (2005)
Perlecan from human epithelial cells is a hybrid heparan/chondroitin/keratan sulfate proteoglycan
S Knox et al.
FEBS LETTERS (2005)
To move or not to move? Semaphorin signalling in cell migration
L Tamagnone et al.
EMBO REPORTS (2004)
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group Trial E2196
JA Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
SR Bramhall et al.
BRITISH JOURNAL OF CANCER (2002)
Directed actin polymerization is the driving force for epithelial cell-cell adhesion
V Vasioukhin et al.
CELL (2000)
分享论文
